510(k) · Cleared
ClearedMedpor Ocular Screw and Acceossories
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Porex Technologies Corp. · MQU Ocular Peg
Cleared on Jun 30, 1997 after a 61-day review. The FDA summary names its predicate without a number. 2 later devices descend from it.
- Decided
- Jun 30, 1997
- Review
- 61 days
- Class
- Class II
- Product code
- MQU
- Recalls
- None
- Predicates
- 0
2 later devices descend from it, 2 citing it directly.
- This deviceK971583 Medpor Ocular Screw and AcceossoriesPorex Technologies Corp. · 1997
- Descendant · cites it directly · 0 of its ownK040851 Medpor Attractor Magnetic Coupling SystemPorex Surgical, Inc. · 2004
- Descendant · cites it directly · 0 of its ownK974203 Perry-Kolberg (PK) Titanium Motility/Support SystemIntegrated Orbital Implants, Inc. · 1998 · Recalled
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K971583 | Medpor Ocular Screw and Acceossories | Porex Technologies Corp. | 1997 | — |
| +1 | K040851 | Medpor Attractor Magnetic Coupling System | Porex Surgical, Inc. | 2004 | — |
| +1 | K974203 | Perry-Kolberg (PK) Titanium Motility/Support System | Integrated Orbital Implants, Inc. | 1998 | 1 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1998 | 1 | 0 |
| 2004 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MQU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | — | Ocular Screw and Accessories Named without a submission number |
What descends from it? (2)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K040851 (Porex Surgical, Inc., 2004) has gone furthest, with 0 descendants of its own.
How does its category compare?
All MQU devicesMQU Ocular Peg: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MQU
FDA has decided no MQU device since 2007.
Median 510(k) review, days · MQU
Too few MQU 510(k)s in any year since 2007 to give a median.
Recalls per year · MQU
No recall names MQU since 2007.
Adverse event reports per year · MQU
1in 2010
MAUDE reports naming product code MQU, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 1 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The MCP® is indicated for patients with MEDPOR® Ocular Implants, who desire improved prosthetic eye motility via direct coupling of the implant to the prosthetic eye. Primary placement of the MCP® may occur during the initial reconstruction procedure, following attachment of the extraocular muscles to the ocular implant but before closing the Tenon’s capsule and the conjunctiva layer. Secondary placement of the MCP may occur typically 3-6 months post enucleation after the ocular implant has become vascularized. Please read additional instructions below.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K971583 · printed Nov 6, 2026
Cite this page
510(k) Report. “K971583: Medpor Ocular Screw and Acceossories.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K971583
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026